Juvenile hyaline fibromatosis
Juvenile hyaline fibromatosis (also known as fibromatosis hyalinica multiplex juvenilis[2] and Murray–Puretic–Drescher syndrome[2]) is a very rare, autosomal recessive disease due to mutations in capillary morphogenesis protein-2 (CMG-2 gene). It occurs from early childhood to adulthood, and presents as slow-growing, pearly white or skin-colored dermal or subcutaneous papules or nodules on the face, scalp, and back, which may be confused clinically with neurofibromatosis.[3] The World Health Organization in 2020 reclassified the papules and nodules that occur in juvenile hyaline fibromatosis as one of the specific benign types of tumors in the category of fibroblastic and myofibroblastic tumors.[4]
| Juvenile hyaline fibromatosis | |
|---|---|
| Other names | Puretic syndrome[1] |
 | |
| Autosomal recessive pattern is the inheritance manner of this condition | |
| Specialty | Dermatology |
Presentation
editThis condition is characterised by abnormal growth of hyalinized fibrous tissue with cutaneous, mucosal, osteoarticular and systemic involvement.
Clinical features include extreme pain at minimal handling in a newborn, gingival hypertrophy, subcutaneous nodules, painful joint stiffness and contractures, muscle weakness and hypotonia.
Genetics
editThis condition is due to mutations in the anthrax toxin receptor-2 (ANTXR2) gene. This gene is also known as capillary morphogenesis protein-2.
This gene is located on the long arm of chromosome 4 (4q21.21).
Management
editThere is no presently known curative treatment for this condition.[citation needed]
Management is supportive.
Prognosis
editPrognosis is very poor with a median age at death of 15 months.[5]
Epidemiology
edit84 cases have been reported as of 2018.[6]
Notable cases
editArgentinian Matías Fernández Burzaco, aged 23, published a book about his experience of the condition, “Formas Propias”.[7] He has also performed as a rap artist.[8]
See also
editReferences
edit- ^ RESERVED, INSERM US14-- ALL RIGHTS. "Orphanet: Juvenile hyaline fibromatosis". www.orpha.net. Retrieved 28 April 2019.
{{cite web}}: CS1 maint: numeric names: authors list (link) - ^ a b Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 978-1-4160-2999-1.
- ^ Freedberg, et al. (2003). Fitzpatrick's Dermatology in General Medicine. (6th ed.). Page 989. McGraw-Hill. ISBN 0-07-138076-0.
- ^ Sbaraglia M, Bellan E, Dei Tos AP (April 2021). "The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives". Pathologica. 113 (2): 70–84. doi:10.32074/1591-951X-213. PMC 8167394. PMID 33179614.
- ^ Davis, J. L. (2020). "Juvenile hyaline fibromatosis". WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. Vol. 3 (5th ed.). Lyon: International Agency for Research on Cancer.
- ^ Casas-Alba D, Martínez-Monseny A, Pino-Ramírez RM, Alsina L, Castejón E, Navarro-Vilarrubí S, Pérez-Dueñas B, Serrano M, Palau F, García-Alix A (2018) Hyaline fibromatosis syndrome: Clinical update and phenotype-genotype correlations. Hum Mutat doi: 10.1002/humu.23638
- ^ "Literature Talk: Own Forms. A Diary of a Body at War | SmartShanghai".
- ^ "BBC News - Out of Shape".